MaiRa
Blood test assessing preeclampsia risk from week 9 of pregnancy
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
MaiRa (Maternal Advanced and Innovative Preeclampsia Risk Assessment) is iPremom's molecular screening test that uses maternal blood cell-free RNA and modelling to estimate early- and late-onset preeclampsia risk from the first trimester. Public sources say it is available in Spain through iPremom's laboratory as a laboratory-developed test, with further clinical validation and EU/US regulatory work underway.
- Website
- ipremom.com/en
- Added via
- web
- Ownership
- unclaimed
Where to go
Product details
- Product kind
- Service